Gene Query: ARL6IP1

Dataset Description Geneva Score
The Role of Histone H3 Lysine 36 Methylation in Reprogramming of fibroblasts and on Induced Pluripotent stem Cell Generation 82.49
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 81.81
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 78.38
Region-specific Innate Antiviral Responses of the Human Epididymis 70.06
RNAseq of HEK293 cells after Chtop knockdown 60.05
Co-transcriptional loading of RNA export factors shapes the human transcriptome 60.05
Poly(ADP-ribosyl)ation dependent changes in CTCF-chromatin binding and gene expression in breast cells 52.79
Coronary Artery Disease Associated Transcription Factor TCF21 Regulates Smooth Muscle Precursor Cells that Contribute to the Fibrous Cap 46.89
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 44.52
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 44.52
A role for ZNF598 in post-transcriptional gene regulation 42.89
RNA-sequencing in irradiated and normal A549 cells. 41.26
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 41.25
Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging 38.46
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma associated herpesvirus ORF57 protein and host pre-mRNA metabolism 37.5
Targeting EZH2 in MYCN-amplified Neuroblastoma 34.43
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 34.43
Uridylation by TUT4 and TUT7 marks mRNA for degradation 32.93
A novel lncRNA GAS1 promotes gastric carcinogenesis and acts as a modular scaffold of WDR5 and KAT2A complexes to specify the histone modification pattern [RNA-seq] 32.1
ChIP-seq and RNA-seq in BGC823 cells after downregulation of GAS1 expression 32.1
NOTCH1 activation in breast cancer confers sensitivity to inhibition of SUMOylation 31.56
KRASG12C inhibition produces a driver-limited state revealing collateral dependencies 31.2
Large-scale expansion of human iPSC-derived skeletal muscle cells for disease modeling and cell-based therapeutic strategies 31.19
ABCB5 is activated by MITF and b-catenin and is associated with melanoma differentiation 31.1
Gene expression changes caused by KRAS in MCF-10A 30.57
GREB1, a novel target of Wnt signaling, promotes development of hepatoblastoma by suppressing TGFβ signaling 30.11
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 29.95
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 27.76
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 26.7
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 26.65
ETS1 acts as a tumor suppressor in breast cancer by inhibiting growth-related factors 26.57
Effect of CHKA knockdown on C4-2 cell transcriptome 26.16
Transcriptomic analysis of human tonsillar TFH subsets 25.45
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 25.07
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites (RNA-seq) 24.99
Replicative senescence is associated with nuclear reorganization and DNA methylation at specific transcription factor binding sites 24.99
Human cell line and subcutaneous tumor 24.92
UBL5 is essential for pre-mRNA splicing and sister chromatid cohesion in human cells 24.75
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 24.58
Solid phase chemistry to covalently and reversibly capture thiolated RNA 24.48
Effects of Cardiac Glycosides on RNA Expression in Prostate Cancer LNCaP-abl Cells 24.25
An RNA-centric dissection of host complexes controlling flavivirus infection 23.96
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 23.96
Derivation of ventrical and atrial cardiomyocytes and maturation using biowires 23.42
A sister of NANOG regulates genes expressed in pre-implantation human development 23.34
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 23.1
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 23.03
Extracellular matrix hydrogel derived from decellularized tissues enables endoderm organoids culture 22.8
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 22.61
NRDE2 negatively regulates nuclear exosome functions 22.13
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 22.12
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 22.12
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 21.78
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 21.43
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 21.39
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 21.33
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing 21.08
Extensive remodeling of DC function by rapid maturation-induced epigenetic gene silencing [RNA-Seq] 21.08
Next Generation Sequencing of isolated EGFR+ and HLA-G+ first trimester human trophoblasts 21.06
Loss of the Chr16p11.2 candidate gene QPRT leads to aberrant neuronal differentiation 20.98
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma 20.71
The role of PHF19 in promoting H3K27me3 deposition in multiple myeloma (RNA-Seq) 20.71
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 20.51
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 20.49
Opposing Effects of Cyclooxygenase-2 (COX-2) on Estrogen Receptor β (ERβ) Response to 5α-reductase Inhibition in Prostate Epithelial Cells 20.45
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 20.38
Differential gene expression tools exhibit substandard performance for long non-coding RNA-sequencing data 20.33
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 20.23
Role of cervicovaginal microbiota in genital inflammation 20.2
Gene Expression Profiling of SPOP Knocked Down Cell 20.13
Regulation of highly expressed hCINAP on translatome 20.13
Role of microRNAs in the interaction between Salmonella and the host cell 20.08
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 [RNA-seq] 19.98
Endogenous interaction profiling identifies DDX5 as an oncogenic coactivator of transcription factor Fra-1 19.98
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 19.89
Profiling of escape kinetics of viruses subjected to RNAi 19.43
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 19.02
Genes directly regulated by NF-κB in human hepatocellular carcinoma HepG2 [RNA-seq] 19.02
Sensing self and nonself circular RNAs 18.95
High RNA polymerase II occupancy on herpes simplex virus 1 late genes early in infection suggests progression to elongation is a critical switch to trigger late viral gene expression 18.86
Genome-wide transcriptional profiling of YAP target genes in human endothelial cells 18.84
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 18.63
Transcriptomic changes mediated by β-amyloid in human aortic endothelial cells (HAOEC) 18.5
RNA-Seq with and without RNase treatment in PCa cell lines 18.34
High level DNA repair gene expression in human ES cells 18.27
TFAP2C signalling in human fibroblasts 18.19
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 18.08
Human serum and heparin-free platelet lysate as appropriate xeno-free alternatives for production of human MuStem cell batches 18.0
MeRIP sequencing reveals angiogenic properties of vascular endothelial cells 17.91
Differetially expressed genes after hTR overexpression in U2OS cells 17.87
Slit2 modifies VEGF-induced angiogenic responses in rabbit skeletal muscle by inducing capillary sprouting and decreasing vascular permeability via reduced eNOS activity 17.85
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 17.34
Circular RNA expression signature of low-glucose-treated MIA PaCa-2 cells 17.26
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 17.21
Primary human trophoblast from term placenta 17.05
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 16.9
Characterization of gene regulation and protein interaction networks for Matrin 3 encoding mutations linked to amyotrophic lateral sclerosis and myopathy 16.8
RNA-seq analysis of A498 cell line treated with siSETD2 or si-NC 16.78
Identification of elevated A-to-I editing sites due to expression of an active ADAR3 mutant in human glioblastoma cells 16.74
Inhibition of SF3B1 by molecules targeting the spliceosome in Rh18 cells 16.61
PER2 synchronizes mitotic expansion and decidual transformation of human endometrial stromal cells 16.59
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 16.57
Neuroligin-4 Regulates Excitatory Synaptic Transmission in Human Neurons 16.21
Inhibition of TNBC metastasis by Gpx1 16.18
Maturation of human iNSCs 16.02
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 15.97
Cell cycle dynamics of human pluripotent stem cells primed for differentiation 15.96
Ribosomal footprinting of CN34-Parental and CN34-LM1a 15.92
Differential gene expression in Jagged1 treated human dental pulp cells. 15.88
15.76
H3B-8800, a novel oral splicing modulator, induces lethality in spliceosome mutant cancers [Nalm-6] 15.5
3’ Uridylation Expands miRNA Target Repertoire 15.5
Inhibition of TAZ contributes radiation-induced senescence and growth arrest in glioma cells 15.46
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 15.42
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 15.42
The comparison of high-throughput single-cell RNA-seq methods 15.38
Human blood CD1c⁺ dendritic cells encompass CD5-high and CD5-low subsets that differ significantly in phenotype, gene expression and functions 15.3
The effect of very-high-molecular-mass hyaluronan (vHMM-HA) on IMR90 transcriptome 15.3
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 15.24
Trisomy of a ‘Down syndrome critical region’ globally amplifies transcription via HMGN1 overexpression [SLAM-Seq] 14.98
Metformin induces chromosome reorganization and changes in gene expression in normal human fibroblasts 14.79
Global analyses of the effect of different cellular contexts on microRNA targeting 14.59
Global analyses of the effect of different cellular contexts on microRNA targeting (RNA-Seq) 14.59
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 14.38
G-quadruplex structures mark human regulatory chromatin 14.37
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer 14.33
DIGIT regulates endoderm differentiation of human embryonic stem cells 14.24
Convergent exaptation of Alu and B/ID SINEs for Staufen-mediated mRNA decay 14.24
METTL3 promotes translation in human cancer cells 14.09
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation (RNA-seq) 14.07
Transcriptional Regulationand Chromatin Dynamics inHuman Epithelial Cell Differentiation 14.07
FOXD3 is a novel tumor suppressor in lung cancer 14.02
SIRT6 regulates redox homeostasis in human mesenchymal stem cells by the transactivation of NRF2 13.96
Comparative Transcriptome analysis of hESCs- and iPSCs-derived lentoid body 13.91
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 13.83
To investigate the decay constants (half-lives) of transcript isoforms generated by alternative polyadenylation in proliferating and quiescent cells 13.78
MYCi361 regulates MYC target genes 13.77
HIV-1 perturbs homeostatic ILCs, unmasks ILC1 plasticity, and boosts TCF7+ memory NK cells 13.67
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 13.66
RNA sequencing from FOXM1 knockout HEK293T cells reconstituted with FOXM1 isoforms a, b and c. 13.62
Gene expression from AsPC-1 cells treated with PTC596 and DMSO 13.6
Nuclear receptor RORγ is a targetable master regulator of cholesterol in a subtype of breast cancer [RNA-Seq] 13.57
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 13.46
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 13.41
Expression level comparison under dividing and quiescent states in human primary fibroblasts 13.4
Gene expression profiling of human and murine in vitro muscle differentiation 13.37
Small-molecule targeting of brachyury transcription factor addiction in chordoma 13.21
Genome wide mapping of polyadenylation sites in proliferating and contact-inhibited cells and cells with knockdown of cleavage and polyadenylation factors 13.08
Ribosomal footprinting of MDA-Parental and MDA-LM2 13.04
RNA-seq analysis in Cornea epithelial cells (CECs), skin epithelial cells (SECs), LSCs after knocking down PAX6 (3-D shPAX6 LSCs) and SESCs transduced with PAX6(3-D PAX6+ SESCs) upon 3-D differentiation 12.97
BET bromodomain inhibitor iBET151 impedes human ILC2 activation and prevents experimental allergic lung inflammation 12.93
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 12.92
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 12.87
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.81
Genome-wide discovery of human splicing branchpoints [RNAse] 12.79
Expansion of adult human pancreatic tissue yields organoids harbouring progenitor cells with endocrine differentiation potential 12.69
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 12.67
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 12.67
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 12.59
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 12.52
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 12.52
Genome-wide transcriptional response to random aneuploidy in human cells 12.42
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 12.41
Detection of internal N7-methylguanosine (m7G) RNA modifications by mutational profiling sequencing 12.38
A Werner syndrome stem cell model unveils heterochromatin alterations as a driver of human aging 12.33
Reduced CYFIP1 in human neural progenitors as 15q11.2 deletion model: donor specific dysregulation of schizophrenia/epilepsy genes 12.32
Monitoring Nivolumab binding as a method to clarify the residual therapeutic effects and to characterize the immune profile in antibody bound T cells in previously treated non-small cell lung cancer patients 12.24
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 12.22
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 12.18
RNA transcriptome analysis during HSV-1 infection 12.08
The human blood-nerve barrier transcriptome 12.04
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 11.96
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 11.96
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 11.92
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 11.89
MYC dependent mRNA translation shapes gene expression and cell biology 11.81
DHX36 is the missing link to understand RNA G-quadruplex structures, mRNA stability, and translation [RNA-seq] 11.73
SIRT7 Antagonizes TGF-β Signaling and Inhibits Breast Cancer Metastasis 11.72
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 11.64
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (human 3' mRNA-seq) 11.62
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 11.58
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 11.42
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 11.38
mRNA gene expression profiling in a human AML cell line treated with small molecule inhibitors that impact different RNA polymerase transcription complexes, or their combination, in comparison to a global DNA-damaging anthracycline compound 11.33
RNA-seq analysis to identify the genes regulated by p53-SET interplay 11.32
Genome-wide expression analysis of human hTert immortalized fibroblasts after donwregulation of MCM7 11.27
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 11.24
Proliferation pause as an early blockade of human cellular reprogramming toward pluripotency [RNA-seq analysis] 11.2
Lentiviral CRISPR Epigenome Editing of Inflammatory Receptors as a Gene Therapy Strategy for Disc Degeneration 11.19
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 11.19
Tyrosine Kinase Inhibitor Cardiotoxicity 11.19
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 11.09
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 11.09
Disruption of the exocyst induces podocyte loss and dysfunction 11.06
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 11.05
CROP-Seq in Primary Human T Cells 11.04
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 11.02
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 11.01
Gene expression profiling of KSHV-infected periodontal ligament cells 10.91
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 10.89
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.82
EIF1AX-A113 splice and RAS mutations cooperate to drive thyroid tumorigenesis through ATF4 and c-MYC 10.79
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 10.78
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 10.78
Transcriptomic analysis of the HOTAIR-regulated genes 10.74
Decrease in EZH2 histone methyltransferase mediates the effects of fluid shear stress (FSS) in endothelial cells 10.74
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation 10.72
Single-cell epigenomics maps the continuous regulatory landscape of human hematopoietic differentiation [bulk RNA-Seq] 10.72
Defining a microRNA-mRNA targetome for calcineurin inhibitor induced nephrotoxicity 10.68
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 10.67
Recruiting Endogenous ADARs with Antisense Oligonucleotides to Reprogram the Transcriptome 10.61
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 10.61
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 10.57
RNA-seq data from human SGBS adipocytes differentiated with marine oxohexadecenoic acids 10.55
Aneuploidy triggers an immune response 10.46
Transcriptome analysis of PRMT6 knock-out in NT2/D1 cells 10.45
Genomic location of PRMT6-dependent H3R2 methylation is decisive for the transcriptional outcome of associated genes 10.45
Role of XRN2 ribonucleolytic activity in RNA metabolism 10.38
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 10.37
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.36
Identification of monocyte-like precursors of granulocytes as a mechanism for accumulation of PMN-MDSC in cancer 10.34
Exploring the RNA landscape of endothelial exosomes 10.11
Alteration of the microRNA network during the progression of Alzheimer’s disease 10.1
Next Generation Sequencing Facilitates Quantitative Analysis of colorectal cancer cells transfected with NC siRNA or RPL9 siRNA 10.04
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 10.04
Nm-seq finds thousands of modified 2’-O-methylation sites in mRNA with base precision 10.02
RNA-seq of cultured human kidney peritubular microvascular endothelial cells following exposure to cyclosporine A 9.97
Identification of PAX7-induced transcriptional changes and PAX7 genomic binding during skeletal myogenic differentiation of H9 embryonic stem cells 9.84
Profiling in vivo Bone Lesion (IVBL) and Orthotopic tumors by Next Generation Sequencing 9.76
RIG-I and MDA5 fRIP during KSHV lytic reactivation 9.72
Reprogramming of human stem cells towards a rejuvenated and transformation-resisting state by recoding a single nucleotide 9.69
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 9.68
K562 polyA RNA-Seq 9.6
RNA-seq from control and macroH2A1-depleted IMR90 primary human lung fibroblasts 9.52
Exploring the role of macroH2A1 in transcription regulation in IMR90 primary human lung fibroblasts with RNA-seq and ChIP-seq 9.52
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 9.42
RNA-Sequencing approach for the identification of novel long non-coding RNA biomarkers in colorectal cancer 9.41
RNA-sequencing 9.37
Conversion of Human Fibroblasts to Stably Self-Renewing Neural Stem Cells with a Single Zinc-Finger Transcription Factor 9.37
Adaptive resistance of melanoma cells to RAF inhibition via reversible induction of a slowly-dividing de-differentiated state 9.36
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 9.36
Analysis of regulatory element evolution between human and mouse reveals a lack of cis-trans compensation 9.33
Single-cell RNA-seq reveals differentiation of bona fide human pDCs and cDC1s in cultures of cord blood CD34+ progenitors, and a newly identified terminal differentiation step of cDC1s 9.32
lncRNA expression analysis in patients with eosinophilic and neutrophilic asthma 9.2
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 9.16
Survival of pancreatic cancer cells lacking KRAS function 9.13
Transcriptome profiling in primary human skeletal myotubes with MondoA knockdown 9.13
MondoA Links Muscle Lipid Accumulation and Insulin Resistance Driven by Nutrient Overload 9.13
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes 9.13
Comprehensive Epigenetic Landscape of Rheumatoid Arthritis Fibroblast-like Synoviocytes [RNA-seq] 9.13
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 9.09
Genome wide mapping of long noncoding (lnc) RNAs in hepatic stellate cells 9.0
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 9.0
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 9.0
Transcriptional changes in lymphoma cells induced by LSD1 depletion 8.87
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 8.87
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription 8.77
Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription [RNA-Seq] 8.77
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 8.74
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 8.74
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 8.72
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 8.51
ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin 8.48
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma 8.47
Global hypomethylation mediated changes regulate constitutive PD-L1 expression in melanoma [RNA-Seq] 8.47
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 8.43
Transcriptomic analysis of the effect of trastuzumab in human iPSC-CMs 8.36
Race-specific transcriptome and Long non-coding RNA of ADT-resistant African-American prostate cancer cell models. 8.35
Mitochondrial dsRNA triggers antiviral signalling in humans 8.26
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 8.25
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 8.14
Gene Expression Analysis of Melanoma Cells Treated with 6-Thio-dG In Vitro 8.14
RNA sequencing, chromatin accesibility and ChIP seq analysis of BAP1 -/- human liver organoids 8.13
Differential gene expression profiles in imatinib-resistant cell lines 8.12
RNA-seq of IL-4 stimulated human keratinocytes 8.07
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 8.0
MCF10A H-Ras RNA-Seq 7.94
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 7.89
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 7.88
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 7.88
Oxaliplatin resistance is enhanced by saracatinib via upregulation of ABCG1 and Wnt/β-catenin signaling in hepatocellular carcinoma 7.86
RNA-Seq of polysome profiling fractions and whole cell lysates of UVB-irradiated N-TERT keratinocytes 7.82
Determination of tRNA aminoacylation levels by high throughput sequencing 7.79
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export II 7.63
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 7.54
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 2: scRNA-seq) 7.51
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 7.48
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development [RNA-seq] 7.46
Multivalent binding of PWWP2A to H2A.Z-marked transcriptional active chromatin regulates mitosis and organ development 7.46
TOP2B disturbed the quality of human oocytes with advanced maternal age 7.43
Single-cell transcriptomics of human oocytes: environment-driven metabolic competition and compensatory mechanisms during oocyte maturation 7.43
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 7.37
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 7.27
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 7.27
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 7.26
Human iPSC-derived cells and microengineered Organ-Chip enhance neural development. 7.13
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 7.09
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 7.05
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 7.05
Nascent RNA Sequencing after NMYC activation in SH-EP MYCNER cells 7.02
Study of dynamic transcriptome profiling in DNA damage-induced cellular senescence and transient cell-cycle arrest 7.01
RNA-seq analysis of SLIRP knockdown with 1nM DHT in LNCaP cells 7.0
Exogenous rescue of KLHL9 in SF210 cell line 6.82
High Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML 6.65
Iron response of HepG2 cells 6.6
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 6.46
RNAseq in Alzheimer's Disease patients 6.41
Transcriptome-wide identification of transient RNA G-quadruplexes in human cells 6.34
Widespread backtracking by RNA pol II is a major effector of gene activation, 5’ pause release, termination and transcription elongation rate 6.14
RNA-Seq analysis of human Tr1, Tregs and IL10neg cells 6.13
Epigenetic profiling and RNA-sequencing of Juvenile Idiopathic Arthritits (JIA) patients 6.11
RNA-sequencing of cells derived from the site of inflammation of Juvenile Idiopathic Arthritis patients 6.11
Comparative Analysis of Cas9 Activators Across Multiple Species 5.96
Human cells contain natural double-stranded RNAs with potential regulatory capacity 5.91
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 5.84
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 5.84
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 5.77
High-throughput sequencing of PROMPT-enriched samples. 5.72
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression 5.66
Distinct structural classes of activating FOXA1 alterations in prostate cancer progression [RNA-Seq] 5.66
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 5.62
Regulatory network controlling tumor-promoting inflammation in human cancers 5.62
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 5.62
Transcriptome Analysis and Functional Identification of Adipose-Derived Mesenchymal Stem Cells in Secondary Lymphedema 5.59
Transcriptomic profiling of mesenchymal stem cells (MSC) differentiation into mesangial cells 5.56
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 5.56
Quantitative Analysis of p53 and/or TGFBR2 Knockdown Endothelial Transcriptomes after Irradiation 5.5
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 5.48
Epidermal growth factor activates β-catenin via integrin-linked kinase to control proliferation of mesenchymal stromal cells. 5.45
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 5.43
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 5.42
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 5.4
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 5.4
Transcriptomic Analysis of Endothelial Cells from Fibrovascular Membranes in Proliferative Diabetic Retinopathy 5.38
Gene expression profiles of rescue with wild type or SUMO double mutant TRIM24 5.26
Nucleosome dynamics in human colorectal cancer specimens reveal activation of a CNOT3-regulated pathway of embryonic stem cell self-renewal 5.23
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 5.06
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 4.98
RNA sequencing of 13 T-cell acute lymphoblastic leukemia patients (5 TCRAD-MYC translocated T-ALL_8TAL1-LMO2 T-ALL) 4.95
RNA-seq of naive and primed ES cells 4.91
4sU-seq of HFF exposed to salt and heat stress 4.9
EWS-Fli and LNC regulated genes in comparison to GFP samples 4.74
Genome-wide expression profiling of B Lymphocytes reveals IL4R increase in allergic asthma 4.67
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 4.64
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 4.58
Identification of differentially expressed genes between senescence and senescence bypass cells 4.57
Expression profile of GIST48 cells with siETV1 or siFOXF1 knockdown 4.54
FOXF1 defines the core-regulatory circuitry in gastrointestinal stromal tumor (GIST) 4.54
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 4.44
Vammin induces a highly efficient angiogenic response through VEGFR-2/NRP-1 and bypasses the regulatory function of VEGFR-1 4.35
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG 4.35
Stable oxidative cytosine modifications accumulate in cardiac mesenchymal cells from Type2 diabetes patients: rescue by alpha-ketoglutarate and TET-TDG functional reactivation [human cells RNA-seq] 4.35
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 4.33
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 4.33
RNA-seq expression data from FL-HSPCs after HOXA7 knockdown 4.27
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 4.23
A single-cell transcriptome atlas of the human pancreas 4.21
mRNA expression in human DAOY cells 4.21
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 4.18
RNA-sequencing analysis of 5' capped RNAs identifies novel differentially expressed genes in sessile serrated colon polyps (SSPs) 4.17
Gene expression changes upon drug withdrawal (A375/451Lu cell lines) 4.15
RNA-Seq of PRMT1 overexpression ECA109 cells 4.06
RNA-Seq with DHT induction and/or GSK treatment at 24, 48 hrs and 2 weeks 4.05
FOXA1 Chromatin Binding is Regulated by LSD1-Mediated Demethylation 4.05
Comparative analysis of mesenchymal stem cells derived from amniotic membrane, umbilical cord and chorionic plate under serum-free condition 4.01
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.97
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation (RNA-seq data) 3.93
Stochastic genome - nuclear lamina contacts are linked to histone H3K9 dimethylation 3.93
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 3.92
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 3.89
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 3.89
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles (RNA-seq) 3.86
CX3CR1/Fractalkine receptor expression separates memory CD8+ T cells with distinct functional profiles 3.86
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 3.86
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 3.81
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 3.81
Transcriptome profiling of Cryptosporidium parvum infected lung and intestinal organoids 3.78
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier [human] 3.67
Oligogenic inheritance of congenital heart disease involving a NKX2-5 modifier 3.67
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 3.67
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 3.64
Aneuploidy-induced cellular stresses limit autophagic degradation. 3.64
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 3.62
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 3.59
Next generation sequencing on knockdown of AC093323.3 in lung cancer cells 3.58
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 3.56
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 3.51
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 3.5
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 3.4
A High-Throughput Screen Identifies DYRK inhibitor ID-8 that Stimulates Human Kidney Tubular Proliferation 3.38
The IMiDs, through loss of Ikaros and Aiolos, primes myeloma cells for daratumumab mediated killing by upregulation of CD38 3.36
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 3.29
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 3.23
Transcriptomic analysis of human coronary artery endothelial cells stimulated with TNF-alpha in the presence and absence of ACSL3 siRNA 3.21
Gene expression profiles of tumor-infiltrating CD8 T cells in hepatocellular carcinoma 3.15
Gene expression profile of multiple myeloma cell lines treated with CB-5083 3.14
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 3.1
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 3.1
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 3.04
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 3.02
Effect of from Human Umbilical Vein Endothelial Cells 2.96
Single Cell Sequencing Reveals Gene Expression Signatures Associated with Bone Marrow Stromal Cell Subpopulations and Time in Culture [NGS_bulk cell RNA-seq] 2.96
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 2.84
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons [RNA-Seq] 2.8
Loss of Nuclear TDP-43 Is Associated with Decondensation of LINE Retrotransposons 2.8
Genes encoding cognate receptors for IRI-related recipient cytokines are expressed in donor livers 2.79
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 2.73
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 2.7
Mutant p53 controls tumor metabolism and metastasis by regulating PGC-1α 2.45
mRNA recovered upon RNF219 IP. [RNA-IP] 2.43
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.4
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.37
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.3
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.29
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.29
High-resolution comparative analysis of great ape genomes 2.25
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis 2.22
SLAM-seq defines direct gene-regulatory functions of the BRD4-MYC axis [Quant-Seq] 2.22
In search for materials able to be colonized by a normal endothelium: сharacterization and NGS gene expression profiling of human primary endotheliocytes cultivated on electrospun 3D matrices 2.22
nELAVL HITS-CLIP in Alzheimer's Disease patients 2.19
IMP3 regulated gene expression in breast cancer cells 2.11
Browning of human adipocytes requires KLF11 and reprogramming of PPARγ super-enhancers 1.97
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.96
Metabolism as an early predictor of DPSCs aging 1.96
Transcriptome of human white and brown adipose tissue biopsies 1.94
Long-term expandable SOX9+ chondrogenic ectomesenchymal cells from human pluripotent stem cells 1.9
GATA2 promotes hematopoietic development and represses cardiac differentiation of human mesoderm 1.88
The transcriptomic landscape of MAIT cell development in the thymus (NN41 RNAseq data set) 1.86
Loss of ANCO1 repression of AIB1/YAP drives breast cancer progression 1.84
EPCR Expression Defines the Most Primitive Subset of Human HSPC and Is Required for Their In Vivo Activity 1.79
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.77
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 1.77
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 1.76
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 1.76
RNA binding protein CPEB1 remodels host and viral RNA landscapes [RNA-Seq] 1.76
Transcriptomic Profiling of Developing Human Paraxial Mesoderm from 4.5-5 Weeks of Gestation Human Embryos 1.66
Aging-associated patterns in the expression of human endogenous retroviruses 1.64
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 1.59
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 1.59
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 1.58
EZH1/SUZ12 complex positively regulates the transcription of NF-κB target genes via interaction with UXT 1.56
miR-126 Orchestrates an Oncogenic Program in B-Cell Precursor Acute Lymphoblastic Leukemia 1.55
Induction of Sertoli-like cells from human fibroblasts by NR5A1 and GATA4 1.54
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.54
Identifying transcripts that are transcriptinoally regulated by CBFB and RUNX1 using RNAseq 1.34
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (pooled infection) 1.33
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.31
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 1.16
WNT signaling memory is required for ACTIVIN to function as a morphogen 1.16
Comparative Transcriptomic Analysis of Hematopoietic System Across Species by Microwell-Seq 1.15
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 1.1
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 1.1
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 1.02
Profiling premalignant lesions in lung squamous cell carcinomas identifies mechanisms involved in stepwise carcinogenesis 1.01
Identification of microRNA-668 and microRNA-489 targets by RISC immunoprecipitation 0.99
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 0.92
Single-cell RNAseq analysis of the empty and i8TF cell lines after 3 days of BL-CFC culture 0.92
Single cell transcriptomics reveals new insights on the dynamical function of transcription factors during blood stem and progenitor cell formation 0.92
Screening in Human Cardiac Organoids Identifies a Requirement for the Mevalonate Pathway in Cardiomyocyte Proliferation 0.85
Coordinated regulation of synthesis and stability of RNA during the acute TNF-induced proinflammatory response 0.85
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.82
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.82
Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance 0.81
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis [RNA-Seq_Hs] 0.8
The Dynamic Epigenetic Landscape of the Retina During Development, Reprogramming, and Tumorigenesis 0.8
Bioreactor-engineered cancer tissues mimic phenotypes, gene expression profiles and drug resistance mechanisms detectable in xenografts and clinical specimens. 0.76
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 0.76
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels [RNA-Seq] 0.7
Differentiation of Induced Pluripotent Stem Cells towards Mesenchymal Stromal Cells is Hampered by Culture in 3D Hydrogels 0.7
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.67
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors [Modifications - screen] 0.63
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [RNA-Seq] 0.63
Genome-Wide DNA Methylation Encodes Cardiac Transcriptional Reprogramming in Human Ischemic Heart Failure [DNA Methylation] 0.63
HEXIM1 is induced by DHODH inhibition to suppress melanoma [Gro-Seq] 0.59
HEXIM1 is induced by DHODH inhibition to suppress melanoma 0.59
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 0.58
Urinary sediment transcriptomic and longitudinal data to investigate renal function decline in type 1 diabetes 0.53
Non-synchronized cell cycle transcriptomics in U2OS and HeLa cancer cells 0.51
Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival 0.51
Assessing placental maturity through histological and transcriptomic analyses in idiopathic spontaneous preterm birth 0.5
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 0.46
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.39
RNA-seq and small RNA-seq from WT and ADAR1 knockdown H9 lines and their differentiation to specific types of neurons 0.38
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.34
Interphase condensins regulate ligand-depedent enhancer activation 0.34
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 0.34
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 0.33
Tracing the temporal-spatial transcriptomic landscapes of the human fetal digestive tract by single cell RNA-seq analysis [adult tissues] 0.27
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.26
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.26
Toxoplasma controls host cyclin E expression through the use of a novel MYR1-dependent effector protein, HCE1 0.25
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.21
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.18
RNA-Seq analysis of human neutrophils isolated by different protocols (Polymorphprep and negative selection) and incubated with and without in vitro cytokine stimulation 0.14
Targets mediated microRNA arm-imbalance promotes gastric cancer progression [lncRNA] 0.09
Regulators of cellular heterogeneity in basal-like breast cancer influence symmetric versus asymmetric division rates (shRNA targeting) 0.05
Glucose inhibits cardiac maturation through nucleotide biosynthesis 0.05
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.04
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.03
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.02


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation